Avadel Pharmaceuticals Plc ADR (AVDL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2019 | 03-2019 | 12-2018 | 09-2018 | 06-2018 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 17,111 | 9,630 | 9,325 | 17,837 | 12,477 |
| Marketable Securities | 62,151 | 70,221 | 90,590 | 107,425 | 134,629 |
| Receivables | 10,172 | 11,772 | 11,330 | 9,725 | 14,940 |
| Inventories | 2,601 | 4,258 | 4,770 | 6,030 | 5,724 |
| Other current assets | 0 | 0 | 283 | 0 | 0 |
| TOTAL | $97,200 | $102,437 | $124,851 | $147,876 | $174,976 |
| Non-Current Assets | |||||
| PPE Net | 934 | 1,749 | 1,911 | 2,288 | 2,439 |
| Intangibles | 19,715 | 19,919 | 20,120 | 87,830 | 89,453 |
| Other Non-Current Assets | 47,860 | 49,517 | 43,418 | 31,012 | 28,368 |
| TOTAL | $68,509 | $71,185 | $65,449 | $121,130 | $120,260 |
| Total Assets | $165,709 | $173,622 | $190,300 | $269,006 | $295,236 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 105 | 104 | 106 | 107 | 108 |
| Accounts payable and accrued liabilities | 4,798 | 4,150 | 3,503 | 11,399 | 11,169 |
| Accrued Expenses | 15,737 | 14,689 | 21,695 | 20,698 | 21,493 |
| Other current liabilities | 11,941 | 11,318 | 13,079 | 13,095 | 17,119 |
| TOTAL | $33,580 | $31,358 | $38,383 | $47,019 | $51,613 |
| Non-Current Liabilities | |||||
| Long Term Debt | 118,631 | 117,178 | 115,734 | 114,382 | 113,038 |
| Deferred Revenues | N/A | 115 | N/A | 1,720 | 1,724 |
| Other Non-Current Liabilities | 31,275 | 34,668 | 33,403 | 41,863 | 52,039 |
| TOTAL | $149,906 | $151,846 | $149,137 | $156,245 | $165,077 |
| Total Liabilities | $183,486 | $183,204 | $187,520 | $203,264 | $216,690 |
| Shareholders' Equity | |||||
| Common Shares | 427 | 427 | 427 | 424 | 421 |
| Retained earnings | -379,612 | -371,007 | -357,989 | -294,130 | -278,359 |
| Other shareholders' equity | -22,846 | -23,201 | -23,414 | -23,649 | -23,657 |
| TOTAL | $-17,777 | $-9,582 | $2,780 | $65,742 | $78,546 |
| Total Liabilities And Equity | $165,709 | $173,622 | $190,300 | $269,006 | $295,236 |